allakos.com - ALLK Net Assets per Single Share
Allakos Inc. (ALLK) faces risks stemming from its narrow specialization in allergy therapy via lirelimateb. The book value per share indicator visualizes current capital, where 0.61 reflects the metric's baseline level. Outsourcing production and testing provides operational flexibility. However, stagnant scaling and strict spending limits create a plateau that restricts the development of the company's assets.
Allakos Inc - analytical breakdowns and key metrics (ALLK)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:allakos.com - ALLK
Book value per share determines the portion of equity attributable to a single share after deducting all liabilities, allowing for an assessment of the asset's intrinsic value regardless of market fluctuations. The book value per share trend reflects the capitalization of Allakos Inc. technological assets, including robotic antibody screening systems, confirming the company's fundamental stability during the automation of preclinical development.
Competitors of Allakos Inc. (ALLK)
ARGX - Net Assets per Single Share|BNTX: Net Assets per Single Share|ABVX: Net Assets per Single Share|ADMA (admabiologics.com) - Book Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|ENGN: Book Value per Share|RAPT Therapeutics, Inc. (RAPT) - Net Assets per Single Share|JBIO (Aerovate Therapeutics) - Net Assets per Single Share|Net Assets per Single Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc.|Book Value per Share TLSA|Book Value per Share CABA (Cabaletta Bio Inc)|Net Assets per Single Share VTYX (Ventyx Biosciences)|theratech.com - Book Value per Share|AVTX (Avalo Therapeutics) - Net Assets per Single Share|ELDN: Net Asset Value per Share|Agenus Inc - Net Assets per Single Share|Net Assets per Share Climb Bio, Inc|ZURA - Accounting Value per Share|Accounting Value of a Share atyrpharma.com|ADAG (Adagene) - Book Value per Share|Net Assets per Share IMA (ikenaoncology.com)|STTK - Net Assets per Single Share|Equity per Share Equillium Inc EQ|CNTB: Book Value per Share|Immunic, Inc. (IMUX) - Accounting Value per Share|atarabio.com - Accounting Value per Share|InflaRx (IFRX) - Net Assets per Share|XFOR (X4 Pharma) - Book Value per Share|Book Value per Share ACET|Net Assets per Single Share Celularity Inc. (CELU)|Net Assets per Single Share INMB (inmunebio.com)|Net Assets per Single Share Barinthus Biotherapeutics plc BRNS|Kezar Life Sciences Inc. - Net Assets per Single Share|SAB Biotherapeutics, Inc - Net Assets per Single Share|AKTX: Book Value per Share|Net Assets per Single Share enlivex.com (ENLV)|Q32 Bio (QTTB) - Share Book Value|GOVX - Book Value per Share|Accounting Value of a Share Edesa Biotech Inc|Book Value per Share IBIO|Book Value per Share CARM (carismatx.com)|Net Assets per Single Share XTL Biopharmaceuticals|Bolt Biotherapeutics Inc. - Accounting Value of a Share|HCWB: Net Assets per Single Share|APVO - Accounting Value per Share|AIM: Book Value per Share|Book Value per Share Aditxt, Inc.|GRI - Accounting Value per Share|Accounting Value of a Share xortx.com|HIND (Vyome Holdings) - Book Value per Share|Net Assets per Share REVB (Revelation Biosciences Inc)|Indaptus - Net Assets per Single Share|BiondVax Pharmaceuticals - Accounting Value per Share|CALI: Net Assets per Single Share|Affimed (AFMD) - Accounting Value per Share|HOOK: Accounting Value per Share|IGMS (IGM Biosciences) - Book Value per Share|Net Assets per Single Share iTeos (ITOS)|Equity per Share Ocean Biomedical Corp|TC Biopharm - Book Value per Share|Net Asset Value per Share thirdharmonicbio.com (THRD)